论文部分内容阅读
本文通过分析AHP层次分析法定量哈药集团生物制药技术能力的影响因子,研究表明科技开发因子是最重要的,其次科研产业,项目管理,融资能力等,提出了如下的措施:应加强科技支持,建立哈药集团与研究机构一体化联合体,增加融资渠道,与生物技术公司结成技术同盟,积极参与国际竞争等措施的结论,以推动生物制药业的发展。
In this paper, AHP AHP is used to quantify the influencing factors of Harbin Pharmaceutical Group’s biopharmaceutical technology capabilities. The research shows that science and technology development factor is the most important, followed by scientific research industry, project management, financing ability, etc. The following measures are proposed: Science and technology support should be strengthened , Establishing an integrated consortium of Harbin Pharmaceutical Group and research institutes, increasing financing channels, forming a technology alliance with biotechnology companies and actively participating in international competition and other measures to promote the development of bio-pharmaceutical industry.